Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis (trifluoromethy1)pheny1)-e thoxy}-methy1)-8-pheny1-1,7-diaza-spir o[4.5] decan-2-one and treatment methods using the same

Details for Australian Patent Application No. 2007233389 (hide)

Owner SCHERING CORPORATION

Inventors Reyderman, Larisa; Qiu, Zhihui

Agent Griffith Hack

Pub. Number AU-A-2007233389

PCT Pub. Number WO2007/114921

Priority 60/789,514 05.04.06 US

Filing date 4 April 2007

Wipo publication date 11 October 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/114921 Priority application(s): WO2007/114921

18 February 2010 Assignment before Grant

  SCHERING CORPORATION The application has been assigned to OPKO Health, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007233445-Control apparatus and control method for multi-room air conditioner

2007233371-Treatments using citrulline